Opendata, web and dolomites

PODIUM SIGNED

PODIUM™ - A home device and cloud-based software and algorithm for diabetic foot ulcer monitoring

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PODIUM project word cloud

Explore the words cloud of the PODIUM project. It provides you a very rough idea of what is the project "PODIUM" about.

lifetime    rapid    dramatically    quality    dfu    consequence    limb    threatening    thermographs    serious    savings    efficacy    esters    sufferers    uk    improvement    caused    premature    5m    pressure       23    considerable    thermetrix    8bn    2015    solution    lower    10x    complications    8m    extremely    12    experiment    ulcers    introduction    decreasing    cloud    imaging    qol    europeans    amounting    risk    detection    conventional    cholesteric    9bn    adults    amputation    percentage    diabetes    diabetics    small    suffer    25    sensitive    85    mortality    2025    diagnostic    diabetic    infrared    60m    cameras    podium    roi    cagr    instead    plus    us       unsuccessful    diagnosis    liquid    ulcer    deaths    generating    complication    sales    global    9m    trade    sensitivity    24    reduce    5bn    model    290       dfus    business    treatment    revealed    prevented    suffering    rate    physicians    reported    life    mainly    effectiveness    foot    456    2024    amputations    crystalline    temperature    solutions    1m    75    450    facilitated    convenience    competitive    healthcare    substantial    subscription    monitoring    grow    validate    market   

Project "PODIUM" data sheet

The following table provides information about the project.

Coordinator
THERMETRIX LTD. 

Organization address
address: TY MENTER NAVIGATION PARK SUITE 12
city: ABERCYNON
postcode: CF45 4SN
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://podium.care/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THERMETRIX LTD. UK (ABERCYNON) coordinator 50˙000.00

Map

 Project objective

'There are 60m adults suffering from diabetes in Europe and 3.8m in UK (5m by 2025). Diabetes has a high mortality rate caused mainly by complications (75,000 deaths p.a., of which 24,000 are premature). One life-threatening complication of diabetes is a diabetic foot ulcer (DFU). Studies revealed a 12% to 25% lifetime risk of developing DFU for diabetics, meaning over 9m Europeans (c.456,000 to 1m in UK) might suffer from DFU in their lifetime. A serious consequence of DFU is lower limb amputation; 85% of the amputations in diabetes sufferers are reported after unsuccessful DFU treatment amounting to 290,000–450,000 amputations/year in Europe, at a cost of €2–2.5bn/year.

The PODIUM™ technology is a novel, extremely reliable and highly sensitive solution for the cost-effective diagnosis and monitoring of DFUs through rapid temperature imaging and reliable analysis of thermographs. PODIUM™ will result in increased numbers of prevented DFUs through 10X higher sensitivity than any competitive solutions. A timely response from physicians, facilitated by PODIUM™ could reduce DFU-related amputations and healthcare costs. Thermetrix’s technology will provide a considerable Quality of Life (QoL) improvement for users and enable substantial savings in healthcare even if only a very small percentage would adopt PODIUM™. The global DFU and pressure ulcers market is expected to grow from US$2.8bn in 2015 to US$4.9bn by 2024 (CAGR 6.6%).

The objectives of this project are (1) experiment with the introduction of liquid crystalline cholesteric esters instead of infrared-cameras as detection method (dramatically decreasing the cost of the method); (2) validate the higher efficacy, diagnostic value, convenience and cost-effectiveness of PODIUM™ over conventional approaches; and (3) validate the business model based on 'unit costs plus cloud subscription' with the aim of generating a ROI of 23:1 based only on European sales only.

'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PODIUM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PODIUM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

VINOQUANT11SUPERPLUS (2019)

A digital based system for measuring, showing and regulation of the complexe system of wine feremtation with high precision via a Bluetooth -Refractometer, a Software and a Bluetooth Thermostat

Read More  

Primavera (2018)

Primavera: immunobiotics for treating early stage Age-related Macular Degeneration (AMD)

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More